These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 36831341)
1. Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer. Singh DD; Lee HJ; Yadav DK Cells; 2023 Feb; 12(4):. PubMed ID: 36831341 [TBL] [Abstract][Full Text] [Related]
2. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring. Zhou Y; Yue Y; Fan S; Jia Q; Ding X Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer. Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835 [TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA landscape in triple-negative breast cancer. Zhang W; Guan X; Tang J Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer. Fan CN; Ma L; Liu N J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs (lncRNAs) in triple negative breast cancer. Wang Q; Gao S; Li H; Lv M; Lu C J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992 [TBL] [Abstract][Full Text] [Related]
7. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer. He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z Gene; 2023 Apr; 860():147227. PubMed ID: 36709879 [TBL] [Abstract][Full Text] [Related]
8. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis. Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151 [TBL] [Abstract][Full Text] [Related]
10. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
11. Progress of non-coding RNAs in triple-negative breast cancer. Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY Life Sci; 2021 May; 272():119238. PubMed ID: 33600860 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198 [TBL] [Abstract][Full Text] [Related]
13. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. Yang Q; Fu Y; Wang J; Yang H; Zhang X J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269 [TBL] [Abstract][Full Text] [Related]
14. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications. Rajagopal T; Talluri S; Venkatabalasubramanian S; Dunna NR Biochem Soc Trans; 2020 Dec; 48(6):2791-2810. PubMed ID: 33258920 [TBL] [Abstract][Full Text] [Related]
15. Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis. Nandagopal S; Misra S; Sankanagoudar S; Banerjee M; Sharma P; Pane SE; Guerriero G; Shukla KK Asian Pac J Cancer Prev; 2023 Jan; 24(1):49-59. PubMed ID: 36708551 [TBL] [Abstract][Full Text] [Related]
16. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer. Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380 [TBL] [Abstract][Full Text] [Related]
17. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis. Zhang H; Wang J; Yin Y; Meng Q; Lyu Y Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33443534 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel long non-coding RNAs in triple-negative breast cancer. Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338 [TBL] [Abstract][Full Text] [Related]
20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]